$0.91
0.25% today
Nasdaq, Nov 26, 06:17 pm CET
ISIN
US6901451079
Symbol
OM

Outset Medical Inc Target price 2024 - Analyst rating & recommendation

Outset Medical Inc Classifications & Recommendation:

Buy
57%
Hold
43%

Outset Medical Inc Price Target

Target Price $3.29
Price $0.90
Potential
Number of Estimates 6
6 Analysts have issued a price target Outset Medical Inc 2025 . The average Outset Medical Inc target price is $3.29. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 7 analysts: 4 Analysts recommend Outset Medical Inc to buy, 3 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Outset Medical Inc stock has an average upside potential 2025 of . Most analysts recommend the Outset Medical Inc stock at Purchase.

Sales and Margin forecast 2024, 2025 to 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Estimates
Revenue Million $ 130.38 112.13
13.00% 14.00%
EBITDA Margin -125.76% -66.67%
6.23% 46.98%
Net Margin -140.24% -118.54%
8.89% 15.47%

7 Analysts have issued a sales forecast Outset Medical Inc 2024 . The average Outset Medical Inc sales estimate is

$112m
Unlock
. This is
2.26% lower
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$112m 2.03%
Unlock
, the lowest is
$112m 2.47%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2023 $130m 13.00%
2024
$112m 14.00%
Unlock
2025
$124m 10.84%
Unlock
2026
$144m 15.89%
Unlock
2027
$158m 9.59%
Unlock
2028
$191m 20.94%
Unlock

4 Analysts have issued an Outset Medical Inc EBITDA forecast 2024. The average Outset Medical Inc EBITDA estimate is

$-74.8m
Unlock
. This is
39.27% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$-74.2m 39.72%
Unlock
, the lowest is
$-75.4m 38.75%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2023 $-164m 5.96%
2024
$-74.8m 54.40%
Unlock
2025
$-50.4m 32.53%
Unlock
2026
$-42.5m 15.73%
Unlock
2027
$-34.3m 19.30%
Unlock
2028
$-5.2m 84.84%
Unlock

EBITDA Margin

2023 -125.76% 6.23%
2024
-66.67% 46.98%
Unlock
2025
-40.58% 39.13%
Unlock
2026
-29.51% 27.28%
Unlock
2027
-21.73% 26.36%
Unlock
2028
-2.72% 87.48%
Unlock

2 Outset Medical Inc Analysts have issued a net profit forecast 2024. The average Outset Medical Inc net profit estimate is

$-133m
Unlock
. This is
8.66% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$-131m 9.75%
Unlock
, the lowest is
$-135m 7.58%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2023 $-183m 2.96%
2024
$-133m 27.30%
Unlock
2025
$-95.4m 28.26%
Unlock
2026
$-83.5m 12.40%
Unlock

Net Margin

2023 -140.24% 8.89%
2024
-118.54% 15.47%
Unlock
2025
-76.73% 35.27%
Unlock
2026
-58.00% 24.41%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 to 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Estimates
Earnings Per Share $ -3.48 -2.53
2.96% 27.30%
P/E negative
EV/Sales 0.66

2 Analysts have issued a Outset Medical Inc forecast for earnings per share. The average Outset Medical Inc <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is

$-2.53
Unlock
. This is
8.66% higher
Unlock
than earnings per share in the financial year 2023. The highest <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS forecast is
$-2.50 9.75%
Unlock
, the lowest is
$-2.56 7.58%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2023 $-3.48 2.96%
2024
$-2.53 27.30%
Unlock
2025
$-1.82 28.06%
Unlock
2026
$-1.59 12.64%
Unlock

P/E ratio

Current -0.33 76.92%
2024
-0.36 9.09%
Unlock
2025
-0.50 38.89%
Unlock
2026
-0.57 14.00%
Unlock

Based on analysts' sales estimates for 2024, the Outset Medical Inc stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of

and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 0.64 49.21%
2024
0.66 3.06%
Unlock
2025
0.60 9.78%
Unlock
2026
0.51 13.71%
Unlock
2027
0.47 8.76%
Unlock
2028
0.39 17.31%
Unlock

P/S ratio

Current 0.41 78.80%
2024
0.42 2.32%
Unlock
2025
0.38 9.77%
Unlock
2026
0.33 13.71%
Unlock
2027
0.30 8.76%
Unlock
2028
0.25 17.31%
Unlock

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today